Phase IIOpenLabel,Multi-CenterClinical Trialof Modulationof Intermediate Endpoint Biomarkersby 1a-HydroxyvitaminD2 in PatientsWithClinically Localized ProstateCancer
نویسندگان
چکیده
Jason Gee,* Howard Bailey, KyungMann Kim, Jill Kolesar, Tom Havighurst, Kendra D. Tutsch, William See, Michael B. Cohen, Nick Street, Leon LeVan, David Jarrard, and George Wilding UniversityofWisconsinCarboneCancer Center,Madison,Wisconsin Medical College ofWisconsin,Milwaukee,Wisconsin TheUniversityof IowaHospitalandClinics, IowaCity, Iowa DepartmentofManagement Sciences, IowaCity, Iowa BoneCareCenter,Middleton,Wisconsin
منابع مشابه
Hypoxia-Inducible Factor-1a (HIF-1a)Gene Polymorphisms,Circulating Insulin-LikeGrowth Factor Binding Protein (IGFBP)-3 Levels and ProstateCancer
Haojie Li,* Glenn J. Bubley, Stephen P. Balk, J. Michael Gaziano, Michael Pollak, Meir J. Stampfer, and Jing Ma Channing Laboratory,DepartmentofMedicine,BrighamandWomen’sHospitalandHarvardMedical School, Boston,Massachusetts DepartmentofMedicine,Beth Israel DeaconessMedical Center;HarvardMedical School, Boston,Massachusetts Divisionof PreventiveMedicine,BrighamandWomen’sHospitalandHarvardMedica...
متن کاملEndpoints of multi-valued cyclic contraction mappings
Endpoint results are presented for multi-valued cyclic contraction mappings on complete metric spaces (X, d). Our results extend previous results given by Nadler (1969), Daffer-Kaneko (1995), Harandi (2010), Moradi and Kojasteh (2012) and Karapinar (2011).
متن کاملPositive Phase III results for Roche’s investigational medicine OCREVUS®
Data from the OCREVUS Phase III studies showed consistent and clinically meaningful reductions in major markers of disease activity and progression compared with Rebif® (interferon beta-1a) in RMS and with placebo in PPMS. The primary endpoint was met in all three studies, which includes relative reduction of annualised relapse rate in the RMS studies and relative reduction in the progression o...
متن کاملSP-SAP Human Clinical Trial for Cancer Pain An Anesthesiologist’s Point of View
been studied in a Phase 1 clinical trial of patients with cancer pain at doses of 1, 2, 4, 8, 16 and 32 mcg. The first patient was treated April 10, 2014. Doses of 64 mcg and 90 mcg remain in Phase 1a of the clinical protocol. Phase 1b will treat multiple patients at the most effective dose. To date, no toxicity has been observed and the study is ongoing to evaluate response, safety, and tolera...
متن کاملThe intermediate endpoint effect in logistic and probit regression.
BACKGROUND An intermediate endpoint is hypothesized to be in the middle of the causal sequence relating an independent variable to a dependent variable. The intermediate variable is also called a surrogate or mediating variable and the corresponding effect is called the mediated, surrogate endpoint, or intermediate endpoint effect. Clinical studies are often designed to change an intermediate o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013